Skip to main content
American Journal of Respiratory and Critical Care Medicine logoLink to American Journal of Respiratory and Critical Care Medicine
letter
. 2022 Jun 23;206(7):921. doi: 10.1164/rccm.202206-1032LE

Comments on Air Pollutant Exposures and COVID-19 Severity and Mortality: Some Concerns on Methodology

Hui-Yuan Chen 1,*, Renin Chang 2,*, James Cheng-Chung Wei 1,3,4,5,
PMCID: PMC9799271  PMID: 35737592

To the Editor:

We read with great interest the epidemiological study by Chen and colleagues investigated the association between ambient pollutant exposures and coronavirus disease (COVID-19) severity and mortality in California during the first wave of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic (1). They concluded that even short-term exposure to air pollution may have an effect on the COVID-19 outcomes. We thank the authors for conducting this retrospective study by collecting information from electronic medical records of a large integrated healthcare system to provide a timely and potentially practical recommendation. We would like to share ideas on this article.

First, the authors have taken many measurable confounders into analysis, and both groups had similar baseline characteristic, such as age, sex, smoking history, body mass index, and Charlson comorbidity score. However, we are concerned about the presence of residual confounding factors associated with the outcomes of the COVID-19 infection, such as that the severity of comorbidities in both groups were not controlled for. For example, patients with chronic lung disease with impaired lung function, as well as patients with cancer who have active anticancer treatment and those with autoimmune diseases receiving immunosuppressants are expected to play important roles for adverse disease outcomes (2, 3).

Second, the interaction between exposure to air pollution and the outcome of patients with COVID-19 infection may vary depending on the age of the subjects (4), and some studies have mentioned a substantial increase in the risk of death related to COVID-19 as air pollution increases, especially in the elderly (5). It would be interesting to readers if this study could be further analyzed to see whether the same trend is observed.

Third, as for the definition of mortality, the authors set the definition of mortality within 60 days after COVID-19 diagnosis. We wonder if COVID-19 infection is the primary diagnosis of death? Or did the authors include deceased cases as long as one of the diagnoses of mortality on the claims-based data was COVID-19? Because air pollution has been mentioned to be associated with cause-specific cardiovascular disease mortality, there may be mediating confounders (6).

In conclusion, we thank the authors for providing this fine ecological study that fills a gap not provided by contemporary studies. However, considering the marginal differences in risk effects due to ambient air pollution, even small biases can have a significant impact on the study results, and we believe the results will be more robust if the above issues are further addressed.

Footnotes

Author Contributions: Substantial contributions to the conception or design of the work; final approval of the version to be published; and agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved: H.-Y.C., R.C., and J.C.-C.W. Drafting the work: H.-Y.C. Revising the work critically for important intellectual content: R.C. and J.C.-C.W.

Originally Published in Press as DOI: 10.1164/rccm.202206-1032LE on June 23, 2022

Author disclosures are available with the text of this letter at www.atsjournals.org.

References

  • 1. Chen Z, Sidell MA, Huang BZ, Chow T, Eckel SP, Martinez MP, et al. Ambient air pollutant exposures and COVID-19 severity and mortality in a cohort of COVID-19 patients in Southern California. Am J Respir Crit Care Med . 2022;206:440–448. doi: 10.1164/rccm.202108-1909OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Chavez-MacGregor M, Lei X, Zhao H, Scheet P, Giordano SH. Evaluation of COVID-19 mortality and adverse outcomes in US patients with or without cancer. JAMA Oncol . 2022;8:69–78. doi: 10.1001/jamaoncol.2021.5148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Akiyama S, Hamdeh S, Micic D, Sakuraba A. Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis. Ann Rheum Dis . 2021;80:384–391. doi: 10.1136/annrheumdis-2020-218946. [DOI] [PubMed] [Google Scholar]
  • 4. Bozack A, Pierre S, DeFelice N, Colicino E, Jack D, Chillrud SN, et al. Long-term air pollution exposure and COVID-19 mortality: a patient-level analysis from New York City. Am J Respir Crit Care Med . 2022;205:651–662. doi: 10.1164/rccm.202104-0845OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Dales R, Blanco-Vidal C, Romero-Meza R, Schoen S, Lukina A, Cakmak S. The association between air pollution and COVID-19 related mortality in Santiago, Chile: a daily time series analysis. Environ Res . 2021;198:111284. doi: 10.1016/j.envres.2021.111284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Hayes RB, Lim C, Zhang Y, Cromar K, Shao Y, Reynolds HR, et al. PM2.5 air pollution and cause-specific cardiovascular disease mortality. Int J Epidemiol . 2020;49:25–35. doi: 10.1093/ije/dyz114. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Respiratory and Critical Care Medicine are provided here courtesy of American Thoracic Society

RESOURCES